Drug development is an incredibly complex and risky endeavor, one that even experienced organizations will fail at more often than they succeed. This introductory course will help you understand how companies structure their efforts and utilize their resources to improve the odds of successful development and minimize the risks associated with shepherding a new drug candidate through the development process.
At the end of this course, you will be able to explain the phases, major work streams, key players, and interrelationships necessary to develop new drugs in the US and Europe and to expand the life cycle of in-line products. Interactive exercises will take you through the many decisions faced by an organization as they progress a new drug candidate through development and beyond.
Join us at the co-located Boston DIA Member Appreciation Reception and Kickoff for DIA 2018 on August 14, 5:30-7:45PM!
Have an account?